Company Filing History:
Years Active: 2021-2025
Title: The Innovative Contributions of Matthew Olding Hebb
Introduction
Matthew Olding Hebb is a notable inventor based in London, Canada. He has made significant strides in the field of medical technology, particularly in the treatment of neurological diseases. With a total of two patents to his name, Hebb's work is paving the way for advancements in brain cell culture and tumor treatment.
Latest Patents
Hebb's latest patents include "Expandable cell populations from brain biopsies of living subjects" and "Intratumoral modulation therapy." The first patent relates to a method of producing expandable cultured brain cells that are neurotrophic factor (NTF) positive. These brain cells are obtained by culturing a biopsy from the cortical and/or subcortical brain region of a living subject, which can be collected during neurosurgical procedures such as deep brain stimulation. This innovation holds promise for treating various neurological diseases and medical conditions. The second patent describes an intratumoral modulation therapy (IMT) method for treating nervous system and systemic tumors. This method involves chronically implanting an electrode adjacent to or within the tumor and applying electric stimulation to facilitate treatment.
Career Highlights
Matthew Olding Hebb is affiliated with the London Health Sciences Centre Research Inc., where he continues to contribute to groundbreaking research. His work focuses on enhancing treatment methodologies for patients suffering from neurological disorders and tumors.
Collaborations
Hebb collaborates with esteemed colleagues, including Susanne Schmid and Eugene Wong, who share his commitment to advancing medical research and innovation.
Conclusion
Matthew Olding Hebb's contributions to medical technology through his patents and research are significant. His innovative approaches to brain cell culture and tumor treatment are set to make a lasting impact in the field of medicine.